Related Experiment Video

Updated: Jun 19, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.4K

Recovery Rates of Diagnostic Cardiac Procedural Volume in Oceania 1 Year Into COVID-19: The IAEA Non-Invasive

Anver Sethwala1, Cole B Hirschfeld2, Patricia O'Sullivan1

  • 1Royal Melbourne Hospital, Melbourne, Vic, Australia.

Heart, Lung & Circulation
|February 16, 2024
PubMed

Insights

Cardiac diagnostic procedure volumes in Oceania returned to pre-pandemic levels one year into the COVID-19 pandemic. Recovery rates for these cardiology procedures did not significantly differ from the rest of the world.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • The COVID-19 pandemic significantly impacted healthcare systems globally, leading to disruptions in routine medical procedures.
  • Assessing the recovery of cardiac diagnostic procedures is crucial for understanding healthcare system resilience.

Purpose of the Study:

  • To evaluate the recovery rates of diagnostic cardiac procedure volumes in the Oceania Region midway through the COVID-19 pandemic.
  • To compare Oceania's recovery rates with the rest of the world (RoW).

Main Methods:

  • A survey compared cardiac diagnostic procedure volumes in March 2019 (pre-pandemic), April 2020 (first wave), and April 2021 (1 year into pandemic).
  • Data from 31 healthcare facilities in Oceania were compared with 549 centers in the RoW.
  • Procedure volumes were analyzed by test type and facility characteristics (metropolitan/regional, public/private, hospital/outpatient, teaching/non-teaching).

Main Results:

  • Oceania performed 11,902 cardiac procedures in April 2021, compared to 11,835 pre-pandemic and 5,986 in April 2020.
  • Total procedure volumes in Oceania recovered to pre-pandemic levels (-6% median change) with no significant difference compared to the RoW (-3% median change).
  • Poorer recovery was suggested for anatomical coronary testing (CT coronary angiography, invasive coronary angiography) in Oceania compared to RoW, though not statistically significant for all measures.

Conclusions:

  • Diagnostic cardiology procedure volumes in Oceania normalized to pre-pandemic levels within one year of the COVID-19 pandemic.
  • No significant differences in recovery rates were observed between Oceania and the RoW, or across different types of healthcare facilities within Oceania.
Abstract

Keywords:
COVID-19Cardiac imagingCardiac investigationsCoronavirus

More Related Videos

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction14:19

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction

Published on: October 14, 2016

11.5K
Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice05:07

Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice

Published on: August 25, 2023

1.0K

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...